- $1.22bn
- $1.27bn
- $606.88m
U.S. STOCKS ON THE MOVE-Hims & Hers, Chewy, Longeveron
U.S. STOCKS ON THE MOVE-Delta, Levi's, banks
Opko Health Rises As Modex Starts Early Trial Of Covid: 19 prevention antibody
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
OPKO Health Q4 revenue falls
Brief: OPKO Health Q4 Net Income USD -31.3 Million
Brief: Opko Health And Entera Bio Expand Partnership To Advance First-In-Class Oral Long Acting Pth Tablet For Patients With Hypoparathyroidism
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
U.S. RESEARCH ROUNDUP- Agios Pharmaceuticals, Dycom Industries, Lowe's Companies
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Healthcare firm OPKO's Q3 revenue falls
Brief: OPKO Health Q3 Net Income USD 21.6 Million
Brief: OPKO Health’s ModeX Therapeutics Enters into Research Collaboration with Regeneron to Develop Multispecific Antibodies for Select Therapeutic Indications
Brief: OPKO Health’s ModeX Therapeutics Begins Clinical Trial Of MDX2004 For The Treatment Of Advanced Cancers
Brief: Labcorp Completes Acquisition Of Select Assets Of BioReference Health's Innovative Oncology And Related Clinical Testing Services Businesses